Home News Page 2

News

WuXi Biologics and NBE-Therapeutics Collaborate in Development and Manufacturing Partnership

WuXi Biologics, an open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Swiss...
Woman Having Chemotherapy With Nurse Using Digital Tablet

Institutional Review Board Approves Phase I Trial with GTB-3550

The University of Minnesota's Institutional Review Board (IRB) and Cancer Protocol Review Committee (CPRC) has granted GT Biopharma (Westlake...

Celltrion Partners with the Canadian Biotech Company, iProgen Biotech to Develop a Series of...

Celltrion signs a partnership deal with the Canada-based iProgen Biotech Inc. to bolster its pipeline for novel biotherapeutics. ...
Featured Image: Pellicon® Capsule. Courtesy: © 2019 MilliporeSigma. Used with permission.

MilliporeSigma Awarded Best New Product at INTERPHEX

MilliporeSigma today announced that it has won an INTERPHEX Exhibitor Award for a new innovation in advancing next- generation...

Triphase’s TRPH-222 enters Clinical Phase I trials

Triphase Accelerator’s TRPH-222, an anti-CD22 antibody-drug conjugate (ADC) for the treatment of patients with lymphoma, has been dosed in...

Mersana Presents Updated Data about its Dolasynthen Platform and Synthemer Scaffold

Clinical-stage bio-pharmaceutical company, Mersana Therapeutics, presented preclinical data from the company's proprietary Dolasynthen platform and its modular Synthemer scaffold...

MilliporeSigma Elevates its BioContinuum™ Platform Strategy to Deliver ‘ContiGuous’ Bioprocessing

MilliporeSigma today unveiled its BioContinuum™ Buffer Delivery Platform, a new building block in the BioContinuum™ Platform for next-generation...
Daiichi Sankyo

Daiichi Sankyo Accelerates BLA Submission for [Fam-] Trastuzumab Deruxtecan in HER2 Positive Metastatic Breast...

Earlier this week Daiichi Sankyo announced plans to accelerate filing of their Biologics License Application (BLA) with the U.S....

Pivotal Trial of Enfortumab Vedotin Shows Positive Topline Results in Locally Advanced or Metastatic...

The first cohort of patients in a pivotal phase II single-arm clinical trial, known as EV-201, shows positive topline...

First-in-class Immunotherapeutic Approach Shows Efficacy in Neuroblastoma

Physician-scientists in the Cancer Center at Children's Hospital of Philadelphia (CHOP) have developed a preclinical, potent therapy attached to...

DOWNLOAD